BCLS Fund IV Investments GP, LLC
Insider CIK 2015967 · KLRA 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KLRA Kailera Therapeutics, Inc. | C Conversion deriv | 2026-04-20 | 2026-04-20 | 4,145,768 | — | $0 | 0 | SEC↗ |
| KLRA Kailera Therapeutics, Inc. | C Conversion deriv | 2026-04-20 | 2026-04-20 | 16,875,000 | — | $0 | 0 | SEC↗ |
| KLRA Kailera Therapeutics, Inc. | C Conversion | 2026-04-20 | 2026-04-20 | 4,145,768 | — | $0 | 21,020,768 | SEC↗ |
| KLRA Kailera Therapeutics, Inc. | P Buy | 2026-04-20 | 2026-04-20 | 1,562,500 | $16.00 | $25.00M | 22,583,268 | SEC↗ |
| KLRA Kailera Therapeutics, Inc. | C Conversion | 2026-04-20 | 2026-04-20 | 16,875,000 | — | $0 | 16,875,000 | SEC↗ |